TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories December 12, 1986
TCL Archive NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions November 7, 1980
TCL Archive Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence July 25, 2008
